financetom
Business
financetom
/
Business
/
Cartesian Therapeutics autoimmune disorder therapy meets main goal of mid-stage study
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cartesian Therapeutics autoimmune disorder therapy meets main goal of mid-stage study
Jul 2, 2024 3:47 AM

July 2 (Reuters) - Cartesian Therapeutics ( RNAC ) said

on Tuesday that its experimental autoimmune disorder therapy met

the main goal of a mid-stage trial.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved